NSEShareholders meeting1d ago · 24 Sept 2026, 05:21 pm

Shareholders meeting

Nath Bio-Genes (India) Limited · NATHBIOGEN

✦ AI SummaryResults

Nath Bio-Genes (India) Limited has held its 33rd Annual General Meeting (AGM) on September 24, 2026, via video conferencing. The meeting passed various resolutions, including the adoption of the audited standalone and consolidated balance sheet, declaration of a final dividend, and re-appointment of directors.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Nath Bio-Genes (India) Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 24, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report.

Attachments (1)

📄

NATHBIOGEN_24092026172046_NBIL_AGM_FY_202526_SIGN_FINAL.pdf

pdf

Download →
View document text
24th September 2026 The Manager-Listing The Manager- Listing BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Bandra (E) Mumbai-400001 Mumbai-400051 BSE Code- 537291 NSE Code-NATHBIOGEN Sub: Summary of Proceedings of 33rd Annual General Meeting of the Company held on Thursday, 24th September 2026 and Scrutinizer's Report of remote e-voting. Ref: Regulation 30 and Regulation 44 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"). Dear Sir/Madam, We wish to inform you that the 33rd Annual General Meeting of the Members of the Company was held on Thursday, 24th September 2026 at 11.00 a.m. via Video Conferencing/Other Audio-Visual Means (VC/OAVM). In this regard, please find the following: Proceedings of 33rd AGM held on 24th September 2026 pursuant to 1. Annexure-I Regulation 30 of the Listing Regulations. Scrutinizer's Report, pursuant to Section 108 of the Companies Act, 2. Annexure-II 2013 on remote e-voting. This is for your information and records. Thanking You. Sincerely, For Nath Bio-Genes (India) Limited Amol Gupta Chief Financial Officer NATH BIO-GENES (INDIA) LIMITED Sr. No. Particulars Details 33rd Annual General Meeting, Thursday, 1 Date of the AGM September 24, 2026 at 11:00 A.M. No. of Shareholders present in the meeting either in person or through 2 Not applicable proxy (Promoters and Promoter Group / Public) No. of Shareholders attended the 3 meeting through Video Conferencing (excluding webcast) Promoters and Promoter Group: 16 Public: 32 Total 48 PROCEEDINGS OF 33RD ANNUAL GENERAL MEETING HELD ON THURSDAY, 24TH SEPTEMBER 2026. 1. Date and Time of the Meeting: The 33rd Annual General Meeting (AGM) of Nath Bio-Genes (India) Limited was held on Thursday, 24th September 2026 at 11.00 A.M. through Video Conferencing (VC)/Other Audio Visual Means (OAVM). 2. Proceeding in brief: ● Mr. Satish Kagliwal, Managing Director, chaired the proceedings of the Meeting. ● The requisite quorum being present, the Chairman called the Meeting to order. ● Directors, Statutory Auditors, Secretarial Auditors and Key Managerial Personnel were present at the Meeting. ● The Chairman informed that the Meeting was being held through Video Conferencing (VC)/Other Audio-Visual Means (OAVM) as per the provisions of the Companies Act, 2013 and circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. ● The Chairman informed that remote e-voting commenced at 09:00 A.M. on Monday, 21st September 2026 and concluded at 5:00 P.M. on Wednesday, 23rd September 2026. ● Replies to the queries/concerns raised by the speaker shareholders were suitably given by the Board. ● The businesses as set out in the Notice convening the AGM were earlier put to vote through remote e-voting. The e-voting was again opened for the Members who were present in the Meeting and who did not cast their vote earlier. 3. Resolutions. The following resolutions as set forth in the AGM Notice were placed: Resolution Sr. Type of Resolution Passed Yes / No. Resolution To receive, consider and adopt the Audited Standalone and Consolidated Balance Sheet of the Company as at 1. March 31, 2026, and the Statement of Profit & Loss for Ordinary Yes the year ended on that date, together with the Reports of Directors and Auditors thereon. To declare a final Dividend of ₹2/- per equity share of 2. face value of ₹10/- each for the financial year ended 31st Ordinary Yes March 2026. To appoint Mrs. Jeevanlata Kagliwal (DIN-02057459) as 3. Director of the Company, who retires by rotation and, Ordinary Yes being eligible, offers herself for re-appointment. Re-appointment of Mr. Hitesh Rajnikant Purohit (DIN- 02340858) as an Independent Director of the Company 4. Special for a second term of five consecutive years from 30th Yes March, 2027 to 29th March, 2032. Revision in remuneration of Mr. Satish Laxminarayan 5. Kagliwal (DIN-00119601), Managing Director of the Ordinary Yes Company 4. Scrutinizer. The Board of Directors had appointed Mrs. Neha P Agrawal, Practicing Company Secretary, as the Scrutinizer to supervise the e-voting process in a fair and transparent manner. 5. Voting by Members. Resolution Nos. 1 to 5 set out in the Notice calling the AGM were passed with the requisite majority . Results of the e-voting are being disseminated to the Stock Exchanges and are also being uploaded on the website of the Company. The Meeting commenced at 11:00 A.M. and concluded at 11:31 AM. This is for your information and records. Thanking You. Sincerely, For Nath Bio-Genes (India) Limited Amol Gupta Chief Financial Officer